Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries. It operates through four segments: Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients. The Biologics segment is a contract development and manufacturing partner for biopharmaceuticals, serving customers for clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies, it also offers specialty raw materials and technology solutions in core target markets, including cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing. The Capsules & Health Ingredients segment provides capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies.